Pharmaceutical Glycerin Based Products Market Size, Share, Competitive Landscape and Trend Analysis Report, by Drug Type : Global Opportunity Analysis and Industry Forecast, 2020-2030

The global Pharmaceutical Glycerin Based Products Market size was valued at $34.6 billion in 2020 and is projected to reach $61.6 billion by 2030, growing at a CAGR of 5.9% from 2021 to 2030. Pharmaceutical glycerin is an organic compound known as glycerol and glycerin and is majorly used as an excipient in the pharmaceutical industry. Glycerin exhibits various benefits in medical and pharmaceutical preparations, such as improving smoothness, lubrication, and humectant. It is most commonly utilized in the formulation of suppositories, cough syrups, elixirs, and expectorants.

The global pharmaceutical glycerin-based product market is driven by the application of glycerin in the treatment of increased eye pressure conditions, such as glaucoma, and during eye surgery fuels the market growth. Furthermore, an increase in the use of glycerin as a substitute for alcohol in hand sanitizers is anticipated to drive the market. In addition, the increase in adoption of glycerin in the pharmaceutical industry owing to its low cost and various medical benefits, such as moisturizer in skin burns & minor skin irritations, and use in the treatment of constipation are the key factors that drive the growth of the market. Moreover, it also exerts osmotic diuretic properties that support the management of cerebral edema and reduces cerebrospinal pressure and intraocular pressure. However, the adverse effects of pharmaceutical glycerin, such as diarrhea, polyuria, nausea, dry mouth, and others hinder the market growth. Ongoing R&D activities related to pharmaceutical glycerin are anticipated to present new Pharmaceutical Glycerin Based Products Market opportunity.

The Pharmaceutical Glycerin Industry market is segmented on the basis of drug type and region. On the basis of drug type, the market is divided into dermatological, ophthalmic, cough remedies glycerin rectal, and angina. On the basis of region, the pharmaceutical glycerin-based product market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

By Drug Type Segment Review

Based on drug type, into dermatological, ophthalmic, cough remedies glycerin rectal and angina. The dermatological segment generated the highest revenue in 2020 and is expected to maintain its dominance during the forecast period. This is attributed to an increase in the prevalence of skin diseases, such as acne, atopic dermatitis, skin cancer, and rosacea, and a rise in demand for topical dermatological products, which are the key factors driving the Pharmaceutical Glycerin Based Products Market growth. However, the glycerin rectal segment is expected to register the highest growth rate during the forecast period.

By Region Segment Review

Region-wise, the Pharmaceutical Glycerin Based Products Market analysis is done across North America, Europe, Asia-Pacific, and LAMEA. Asia-Pacific accounted for the largest Pharmaceutical Glycerin Based Products Market share in 2020. The growth can be attributed to the rapidly increasing consumption of pharmaceutical glycerin-based products in countries, such as China, India, and South Korea.

The key players operating in the global pharmaceutical glycerin-based product market include Johnston & Johnson, Abbott, AbbVie Inc. Bausch Health Companies Inc, Takeda Pharmaceutical Companies, The Dow Chemical Company, Dupont, Emery Oleochemicals, Croda International Plc, and Lonza.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pharmaceutical glycerin-based products market analysis from 2020 to 2030 to identify the prevailing pharmaceutical glycerin-based products market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the pharmaceutical glycerin-based products market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global pharmaceutical glycerin based products market trends, key players, market segments, application areas, and market growth strategies.

  Pharmaceutical Glycerin Based Products Market Report Highlights

Aspects	Details
By Drug Type	Dermatological Opthalmic Cough Remidies Glycerine Rectal Angina
By Region	North America  (U.S., Canada, Mexico) Europe  (Germany, France, U.K., Italy, Spain, Rest of Europe) Asia-Pacific  (Japan, China, Australia, India, South Korea, Rest Of Asia Pacific) LAMEA  (Brazil, South Africa,, Saudi Arabia, Rest of LAMEA)
Key Market Players	Takeda Pharmaceutical Company, AbbVie Inc, Abbott Laboratories, Johnson and Johnson, Bausch Health Companies Inc., Capsugel, dupoint, Croda International plc, The Dow Chemical Company, Takeda Pharmaceutical Company Ltd, Emery Oleochemicals

Analyst Review

The pharmaceutical glycerin-based products market is expected to witness substantial growth owing to an increase in the use of glycerin as a substitute for alcohol in hand sanitizers.

In addition, the increase in adoption of glycerin in the pharmaceutical industry owing to various medical benefits, such as moisturizer in skin burns & minor skin irritations, and cough syrups for dry cough are the key factors anticipated to drive the growth of the market in the upcoming years and in treatment of constipation. Moreover, it also exerts osmotic diuretic properties that support the management of cerebral edema and reduces cerebrospinal pressure and intraocular pressure. However, the adverse effects of pharmaceutical glycerin, such as diarrhea, polyuria, nausea, dry mouth, and others hinder the market growth. Ongoing R&D activities related to pharmaceutical glycerin are anticipated to present new opportunities for the market.

Asia-Pacific accounted for the major share and is likely to dominate the market during the forecast period. The growth can be attributed to the rapidly increasing consumption of the pharmaceutical glycerin-based product in countries such, as China, India, and South Korea.

Author Name(s) : Vikita Thakur | Roshan Deshmukh

Related Tags

• Dermatology
• Scar Treatment
• Capsules

^*Terms and Conditions Apply